Cannabidiol (CBD) has anti-tumorigenic activity. However, the anti-cancer effect of CBD on
head and neck squamous cell carcinoma (HNSCC) remains unclear. The cytotoxicity of CBD …

BACKGROUND Plant-derived cannabinoids have shown efficacy in GBM animal models
when co-administered with TMZ. Activation of an endoplasmic reticulum stress-related …

Background The transcription factor NF-κB drives neoplastic progression of many cancers
including primary brain tumors (glioblastoma [GBM]). Precise therapeutic modulation of NF …

Malignant glioma is the most common primary brain tumor, and its high ability to invade the
surrounding brain parenchyma is a leading cause of tumor recurrence and treatment failure …

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary
malignant brain tumor in adults, with poor prognosis. Extracellular vesicles (EVs) are key …

Glioma is the most common primary malignant brain tumor with poor survival and limited
therapeutic options. The non-psychoactive phytocannabinoid cannabidiol (CBD) has been …

Simple Summary Cannabidiol (CBD) is a phytocannabinoid from Cannabis sativa L. that
exhibits no psychoactivity and, like the psychoactive cannabinoid Δ9-tetrahydrocannabinol …

Simple Summary Pancreatic cancer (PC) is related to lifestyle risks, chronic inflammation,
and germline mutations. Surgical resection and adjuvant chemotherapy are the main …

Cannabinoids have been utilized for recreational and therapeutic purposes for over 4,000
years. As the primary ingredient in exogenous cannabinoids, Cannabidiol (CBD) has drawn …

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults. The
challenging problem in cancer treatment is to find a way to upregulate radiosensitivity of …